Clinical Trial Update: Evaluation of Intravenous Lidocaine and Time to Regression of the Sensory Block After Spinal Anesthesia (ELSA Trial) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating intravenous lidocaine and time to regression of the sensory block after spinal anesthesia (ELSA Trial) spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia
• Cancer

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Anesthesia, Cancer | Phase 2, Phase 3 | Status: UNKNOWN